A Study of Single and Multiple Ascending Doses of VIB1116 in Rheumatic Diseases

Clinical trial NCT04948099 · COMPLETED

Trial details

NCT number: NCT04948099
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Dendritic Cell -Mediated Rheumatic Diseases

Start date: 2021-07-06
Primary completion: 2023-07-03
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.